Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders: stigma/consequence of unresolved early infectious events?
暂无分享,去创建一个
R. Delorme | M. Leboyer | P. Debré | M. Bouvard | N. Tarantino | A. Gaman | R. Tamouza | V. Vieillard | A. Amestoy | M. Caralp | S. Guéguen | I. Scheid | R. Krishnamoorthy | A. Bouleau | M. Bennabi | Myriam Ly Le-Moal
[1] F. Guerini,et al. HLA-G allelic distribution in Sardinian children with Autism spectrum disorders: A replication study , 2019, Brain, Behavior, and Immunity.
[2] P. Trerotoli,et al. Subtyping the Autism Spectrum Disorder: Comparison of Children with High Functioning Autism and Asperger Syndrome , 2018, Journal of autism and developmental disorders.
[3] C. Nevison,et al. California Autism Prevalence Trends from 1931 to 2014 and Comparison to National ASD Data from IDEA and ADDM , 2018, Journal of autism and developmental disorders.
[4] F. Guerini,et al. HLA-G coding region polymorphism is skewed in autistic spectrum disorders , 2018, Brain, Behavior, and Immunity.
[5] R. Delorme,et al. Social cognition in autism is associated with the neurodevelopment of the posterior superior temporal sulcus , 2017, Acta psychiatrica Scandinavica.
[6] F. Guerini,et al. HLA-G∗14bp Insertion and the KIR2DS1-HLAC2 Complex Impact on Behavioral Impairment in Children with Autism Spectrum Disorders , 2017, Neuroscience.
[7] E. Susser,et al. Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring , 2017, mSphere.
[8] Philip D. Zisman,et al. Variation in Gene Expression in Autism Spectrum Disorders: An Extensive Review of Transcriptomic Studies , 2017, Front. Neurosci..
[9] P. Bray-Ward,et al. Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum Disorder , 2016, Front. Neurosci..
[10] I. Cremer,et al. Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome , 2016, The Journal of Immunology.
[11] M. Posada,et al. Characterization of immune cell phenotypes in adults with autism spectrum disorders , 2016, Journal of Investigative Medicine.
[12] Maureen S. Durkin,et al. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012 , 2018, Morbidity and mortality weekly report. Surveillance summaries.
[13] Tony Charman,et al. Diagnosis of autism spectrum disorder: reconciling the syndrome, its diverse origins, and variation in expression , 2016, The Lancet Neurology.
[14] D. Geschwind,et al. Gene hunting in autism spectrum disorder: on the path to precision medicine , 2015, The Lancet Neurology.
[15] R. Delorme,et al. Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders? , 2015, PloS one.
[16] A. McAllister,et al. Immune mediators in the brain and peripheral tissues in autism spectrum disorder , 2015, Nature Reviews Neuroscience.
[17] P. Debré,et al. Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[18] C. Lord,et al. Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. , 2015, Annual review of clinical psychology.
[19] Igor Burstyn,et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders , 2015, Brain, Behavior, and Immunity.
[20] Cathleen K. Yoshida,et al. Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study , 2014, Journal of Neuroinflammation.
[21] B. Goldstein,et al. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.
[22] C. Carcassi,et al. Activating KIR molecules and their cognate ligands prevail in children with a diagnosis of ASD and in their mothers , 2014, Brain, Behavior, and Immunity.
[23] P. Debré,et al. Expansion of CMV-Mediated NKG2C+ NK Cells Associates with the Development of Specific De Novo Malignancies in Liver-Transplanted Patients , 2014, The Journal of Immunology.
[24] H. Qin,et al. New insights into the genetic mechanism of IQ in autism spectrum disorders , 2013, Front. Genet..
[25] É. Vivier,et al. The speed of change: towards a discontinuity theory of immunity? , 2013, Nature Reviews Immunology.
[26] J. Orange. Natural killer cell deficiency. , 2013, The Journal of allergy and clinical immunology.
[27] K. Campbell,et al. Natural killer cell biology: an update and future directions. , 2013, The Journal of allergy and clinical immunology.
[28] A. Whitehouse,et al. Autism spectrum disorder in children born preterm—role of exposure to perinatal inflammation , 2013, Front. Neurosci..
[29] F. Hentges,et al. NK Cells in Central Nervous System Disorders , 2013, The Journal of Immunology.
[30] H. Ljunggren,et al. Spotlight on NKG2C and the human NK‐cell response to CMV infection , 2012, European journal of immunology.
[31] D. Ward,et al. Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism , 2012, Brain, Behavior, and Immunity.
[32] Marion Leboyer,et al. Autism risk factors: genes, environment, and gene-environment interactions , 2012, Dialogues in clinical neuroscience.
[33] N. Wauquier,et al. Unconventional Repertoire Profile Is Imprinted during Acute Chikungunya Infection for Natural Killer Cells Polarization toward Cytotoxicity , 2011, PLoS pathogens.
[34] Lewis L. Lanier,et al. NK cell development, homeostasis and function: parallels with CD8+ T cells , 2011, Nature Reviews Immunology.
[35] P. Patterson,et al. Maternal infection and immune involvement in autism. , 2011, Trends in molecular medicine.
[36] D. Amaral,et al. In Search of Cellular Immunophenotypes in the Blood of Children with Autism , 2011, PloS one.
[37] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[38] C. Bagnis,et al. RAE‐1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres , 2011, Glia.
[39] H. Coon,et al. Narrowing the broader autism phenotype , 2010, Autism : the international journal of research and practice.
[40] P. Debré,et al. Human NK cells display major phenotypic and functional changes over the life span , 2010, Aging cell.
[41] E. Wherry,et al. Redefining Chronic Viral Infection , 2009, Cell.
[42] P. Gaulard,et al. STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma , 2009, Leukemia.
[43] M. Kemeny,et al. Psychobiological responses to social threat: Evolution of a psychological model in psychoneuroimmunology , 2009, Brain, Behavior, and Immunity.
[44] J. Gregg,et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism , 2009, Brain, Behavior, and Immunity.
[45] Jaquelyn B. McCandless,et al. Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15 , 2008, Journal of Neuroimmunology.
[46] C. Vilches,et al. Facilitation of KIR genotyping by a PCR-SSP method that amplifies short DNA fragments. , 2007, Tissue antigens.
[47] S. Gasser,et al. Activation and self‐tolerance of natural killer cells , 2006, Immunological reviews.
[48] Pat Levitt,et al. A genetic variant that disrupts MET transcription is associated with autism , 2006, Proceedings of the National Academy of Sciences.
[49] F. Bolgert,et al. Persistence of CD16+/CD56−/2B4+ natural killer cells: A highly dysfunctional NK subset expanded in ocular myasthenia gravis , 2006, Journal of Neuroimmunology.
[50] H. Westenberg,et al. Decreased TNF-α and NK activity in obsessive-compulsive disorder , 2004, Psychoneuroendocrinology.
[51] Stephanie Hayes,et al. The factor structure of autistic traits. , 2004, Journal of child psychology and psychiatry, and allied disciplines.
[52] R. Gelman,et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. , 2003, The Journal of allergy and clinical immunology.
[53] B. Leventhal,et al. The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.
[54] R de Groot,et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. , 1997, The Journal of pediatrics.
[55] J. Gilmore,et al. Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. , 1992, Archives of general psychiatry.
[56] G. Nahler,et al. Replication Study , 2017 .
[57] R. Warren,et al. Reduced natural killer cell activity in autism. , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.
[58] Judy Van de Water,et al. The Role of the Immune System in Autism Spectrum Disorder , 2017, Neuropsychopharmacology.
[59] John Quackenbush,et al. Genesis: cluster analysis of microarray data , 2002, Bioinform..